Thinking of joining a study?

Register your interest

NCT06709404 | RECRUITING | Hematopoietic and Lymphatic System Neoplasm


Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
Sponsor:

Wake Forest University Health Sciences

Brief Summary:

This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general belief in the ability to cope with daily life. Caregivers of patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC) demonstrate that they endure high depressive symptom burdens and financial distress. Further, they experience symptom trajectories that differ from those of patients. In short, they require differential timing of supportive interventions. This study aims to reduce financial toxicity and distress levels and to increase self-efficacy, satisfaction and engagement with care. Information gathered from this study may help researchers determine whether telehealth interventions for caregivers may increase awareness of recommended resources that could be beneficial during caregivers journey.

Condition or disease

Hematopoietic and Lymphatic System Neoplasm

Malignant Solid Neoplasm

Intervention/treatment

Telemedicine

Survey administration

Electronic health record review

Best Practice

Phase

NA

Detailed Description:

PRIMARY OBJECTIVE: I. To assess the feasibility of a telehealth navigation intervention for CS+HIPEC caregivers. SECONDARY OBJECTIVES: I. To assess the efficacy of the intervention on financial distress and depression in intervention and standard of care caregivers. II. To compare financial distress in intervention caregivers as compared to standard of care caregivers. III. To compare satisfaction with care experiences in intervention caregivers as compared to standard of care caregivers. IV. To compare self-efficacy for navigating treatment-related costs in intervention caregivers as compared to standard of care participants. V. To compare self-reported community resource use among intervention and standard of care caregivers. VI. To compare the quality of life over time in intervention caregivers as compared to standard of care caregivers. VII. To compare social support over time in intervention caregivers as compared to standard of care caregivers. VIII. To compare treatment satisfaction for intervention caregivers as compared to standard of care caregivers. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive telehealth navigation intervention which may consist of referral to specific resources for caregiving experience over 1 hour 1-4 weeks prior to patient's surgery. GROUP II: Participants receive standard caregiving experience on study. After completion of study intervention, participants are followed up at 3, 6, 12, and 24 months.

Study Type : INTERVENTIONAL
Estimated Enrollment : 50 participants
Masking : NONE
Primary Purpose : SUPPORTIVE_CARE
Official Title : Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Actual Study Start Date : 2025-01-31
Estimated Primary Completion Date : 2026-12
Estimated Study Completion Date : 2026-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Primary caregiver of a patient scheduled to receive CS+HIPEC
  • * Access to a computer or smartphone and must have an email address
  • * 18 years of age or older
  • * The ability to understand and willingness to provide written informed consent
  • * The ability to read and write English
  • Exclusion Criteria
  • - Patient declines access to their medical record

  • Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

    Location Details

    NCT06709404


    Please Choose a site



    How to Participate

    Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

    Locations


    RECRUITING

    United States, North Carolina

    Wake Forest Baptist Comprehensive Cancer Center

    Winston-Salem, North Carolina, United States, 27157

    Loading...